Vimarsana
Biggest News Aggregation in the World

Page 17 - Daniel Vitt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Daniel Vitt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Daniel Vitt Today - Breaking & Trending Today

EQS-News: Immunic, Inc.: Immunic to Participate in Scientific and Industry Conferences in October - Vimarsana News

EQS-News: Immunic, Inc.: Immunic to Participate in Scientific and Industry Conferences in October

Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Scientific and Industry Conferences in October 04.10.2022 / 12:30 CET/CEST The issuer is solely responsible

Immunic to Participate in Scientific and Industry Conferences in October - Vimarsana News

Immunic to Participate in Scientific and Industry Conferences in October

/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused...

EQS-News: Immunic to Participate in Scientific and Industry Conferences in October - Vimarsana News

EQS-News: Immunic to Participate in Scientific and Industry Conferences in October

Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Scientific and Industry Conferences in October 04.10.2022 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Participate in Scientific and Industry Conferences in October NEW...

EQS-News: Immunic to Participate in Scientific and Industry Conferences in October Seite 1 - Vimarsana News

EQS-News: Immunic to Participate in Scientific and Industry Conferences in October Seite 1

04.10.2022 - Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Scientific and Industry Conferences in October 04.10.2022 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Participate in ... Seite 1

EQS-News: Immunic, Inc.: Immunic Announces Positive Results from Single and Multiple Ascending Dose Parts of Its Phase 1 Clinical Trial of IMU-856 in Healthy Human Subjects - Vimarsana News

EQS-News: Immunic, Inc.: Immunic Announces Positive Results from Single and Multiple Ascending Dose Parts of Its Phase 1 Clinical Trial of IMU-856 in Healthy Human Subjects

Issuer: Immunic, Inc. / Key word(s): Study results Immunic Announces Positive Results from Single and Multiple Ascending Dose Parts of Its Phase 1 Clinical Trial of IMU-856 in Healthy Human